Castle Biosciences adopts amended bylaws with changes to meeting procedures and governance

CASTLE BIOSCIENCES INC

Board adopted amended and restated bylaws effective August 5, 2025, modifying quorum, advance notice, and proxy rules.
Advance notice window for stockholder proposals widened: meeting delayed >70 days (previously 30) triggers alternative deadline.
Quorum changed from majority of outstanding shares to majority of voting power; default approval threshold now majority of votes cast.
Universal proxy rules under Rule 14a-19 incorporated; stockholder nominees limited to number of directors to be elected.
Indemnification obligations expanded to maximum extent allowed by law; mandatory advancement of expenses clarified.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

CASTLE BIOSCIENCES INC: Adopted amended and restated bylaws effective August 5, 2025, with multiple changes including stockholder meeting procedures, quorum thresholds, and nomination requirements (effective 2025-08-05).

Change: bylaw amendment
Effective: 2025-08-05

Exact text from the filing

On August 5, 2025, the board of directors (the “Board”) of Castle Biosciences, Inc. (the “Company”) adopted amended and restated bylaws of the Company (as amended and restated, the “A&R Bylaws”), effective as of such adoption date.

View on SEC.gov

Browse all governance changes →

CASTLE BIOSCIENCES INC filing history →

Source: SEC EDGAR

accession 0001447362-25-000099

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.